COPD Flashcards

1
Q

what are the receptors in the airways

A

muscarinic acetylcholine receptors

M1, M2, M3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

location of M1 receptor in the airways

A

Ganglia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

role of M1 receptor

A

Facilitate fast neurotransmission mediated by ACh acting on nitcotinic receptors (nAChR)
Increase action potential frequency from nicotinic receptor stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

location of M2 receptors

A

postganglionic neurone terminals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

role of M2 receptors

A

inhibitory autoreceptors reduce release of Ach (blockade)

Increase release of Ach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Location of M3 receptors

A

airway smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

role of M3 receptors

A

mediate contraction in response to Ach

present on mucus secreting cells causing increased secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is COPD

A

increased resistance to airflow during expiration (no problem breathing in only on exhalation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

why does a person with COPD struggle to exhale

A

airways + alveoli lose elastic quality
walls between alveoli destroyed
airway walls inflamed
airways clogged by mucus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what causes COPD and airway obstruction to progress

A

muscular dysfunction
inflammation
Tissue damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what two conditions contribute to COPD

A

emphysema + chronic bronchitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is emphysema

A
Alveolar destruction (loss of alveoli walls)
Impaired gas exchange 
Loss of bronchial support
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

emphysema is reversible/irreversible

A

irreversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how does emphysema occur

A

protease -> alveolar destruction -> emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is chronic bronchitis

A

chronic neutrophilic inflammation
Mucus hypersecretion
Mucociliary dysfunction
Altered lung microbiome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what cells are a marker for COPD

A

neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

chronic bronchitis is reversible/irreversible

A

(partly) reversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what effect does chronic bronchitis have on airway smooth muscle

A

smooth muscle spasm + hypertrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

who gets COPD

A

smokers, those exposed to smoking, pollutants, chemical fumes, dusts or AAT deficient people

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

list the symptoms

A
Daily mucus/sputum cough
Progressive Breathlessness
Wheezing (chronic bronchitis)
Chest tightness
Lips & fingers blue/grey = hypoxic
Exacerbations 
Reduced lung function
Chronic symptoms: not episode
reduced breath sounds (emphysema)
Dysponea (difficult/laboured breathing)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

main symptoms of chronic bronchitis

A

wheezing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

main symptom of emphysema

A

reduced breath sounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what tests are used to diagnose COPD

A
spirometry (pulmonary function test)
Chest X ray
Chest CT scan 
Arterial blood gas test (measures O2)
Blood Test: neutrophils present
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

how is spirometry carried out

A

patient blows into spirometer after max inspiration as hard and fast as possible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
how is spirometry used to tell if a patient has COPD
airways more constrictive in COPD so FVC reduced due to gas trapping/decreased residual volume FVC & FEV1 both reduced
26
In a patient with COPD their FEV1 in response to a B2 agonist is
less than 15%
27
what effect does smoking cessation have as treatment for COPD
``` FEV1 falls gradually in non-smokers, FEV1 in smoker is rapid, FEV1 cannot be restored but ht falling FEV1 rate can be reverted to normal after long period of not smoking early screening nicotine patches bupropion Varenicline ```
28
What immunisations help protect against COPD patients
pneumococcal | influenza
29
what is the aim O2 sats for a COPD patient
88% - 92%
30
what mask must COPD patients get O2 from
venturi
31
what percentage of oxygen must COPD patients be given
24% - 28%
32
why must COPD patients be given controlled Oxygen
prevent hypercarbia (COPD patients cannot efficiently get rid of CO2 - poor ventilation - so CO2 builds up) causing respiratory acidosis
33
how does renal compensation work
high conc of CO2 in blood detected by kidneys and renal secretion of HCO3 to counterbalance
34
how are muscarinic antagonists used to treat COPD
inhaled block post junctional end plate M3 receptor activation by preventing contraction (bronchoconstriction) by preventing Ach binding to receptor Antagonist of M3 smooth muscle receptor activation in response to ACh released from postganglionic parasympathetic fibres and epithelial cells
35
benefit of muscarinic antagonists acting against M3
high therapeutic ratio (Safe) | reduces exacerbations
36
describe the steps of airway smooth muscle contraction Brought about by the binding of Ach to M3
Ach binds to M3 receptor, signal to Gq/11 signal to PLC causing PIP2 -> IP3, IP3 causes release of calcium from sacropasmic reticulum, intermediate steps involve calmodulin and MLCK leading to contraction
37
types of muscarinic antagonsits
Ipratropium (SAMA - short acting) | LAMA: tiotropium, Glycopyrronium, Aclidinium, Umedlidinium, Aclidinium bromide
38
how does ipratropium work
delayed bronchodilator - reduces bronchospasm | non-selective blocker of M1, M2, M3
39
what is the effect of treating a patient with a LAMA or SAMA
decreased mucus secretion | no effect on COPD progression
40
how is ipratropium given
high nebulised dose
41
ipratropium and tiotropium have a quaternary ammonium group what is the benefit of this
reduces absorption/systemic exposure | avoids multiple AP adverse effects of a generalised parasympathetic block
42
what does atropine posses
tertrial amine
43
how do B2 agonists help COPD patients
b-adrenoceptors inhaled causing bronchodilation
44
does salbutamol help reduce inflammation
NO! only bronchodilation
45
what are the short acting B2 agonists
salbutamol 4-6h
46
what are the long acting B2 agonists
salmeterol/formoterol (2x day) | indacaterol/olodaterol (ultra LABA) once daily
47
most effective way to relax the airways of a COPD patient during exacerbation
LABA/LAMA combo inhaler increases FEV1 both drugs in same airway location (act on same ligand)
48
what treatment would be given to a COPD patient having few (<2 exacerbation)
Glycophyrronium/indacterol
49
what treatment would be given to a COPD patient having sever/frequent (>2) exacerbations
LABA and/or LAMA + ICS (co-adminstered with glucocorticoid)
50
what effect does administering a glucocorticoid have on COPD patient
reduces inflammation
51
when would glucocorticoid be co-administered with LAMA/LABA
high eosinophil count
52
when can glucocorticoid be unresponsive in COPD patients
Oxidative/nitrative stress due to chronic inhalation of tobacco or if HDAC2 reduced
53
what is an adverse effect of co-administering a glucocorticoid
can cause pneumonia as local immune suppression altered microbiome and impairs MC clearance
54
why is fluticasone more likely to cause predisposition to pneumonia
it causes prolonged lung retention
55
give examples of ICS/LABA/LAMA triple inhaler
beclomethasone formoterol glycopyrronium
56
when would a triple inhaler like beclomethasone, formoterol or glycopyrronium be used
once daily for moderate/severe COPD | NOT for asthma/acute bronchospasm
57
what would be given as an add on therapy, given orally, to reduce exacerbations in people with severe COPD + chronic bronchitis
Rofumilast: | inhibitor of PDE4 (PDE4 expressed on neutrophils, T cells and macrophages surpasses inflammation and emphysema
58
adverse effects of rofumilast
GI effects, nausea, headache
59
What add on therapy is used to reduce exacerbations by reducing sputum viscosity and aide sputum expectoration
mucolytis: oral carbocisteine or erdosteine
60
how would you treat a patient with acute COPD
nebulised high dose salbutamol (LABA) + ipratropium (LAMA) oral prednisolone (steroid) antibiotic (amoxycillin/doxycycline) if infection eg. high eosinophils 24-28% O2 via Venturi against PaO2/PaCO2 physic to aide sputum expectoration Non-invasive ventilation allowing higher FiO2 (inspired O2) ITU intubated assisted ventilation (only if reversible component eg. Pneumonia)
61
what does the prognosis of COPD depend on
FEV1: higher the FEV1 = decreased exacerbations = good prognosis
62
describe the chronic cascade in COPD
Progressive fixed airflow obstruction Impaired alveolar gas exchange Respiratory failure: decreased PaO2 Increased PaCO2 Pulmonary hypertension Right ventricular hypertrophy/failure (i.e. cor pulmonale) Death